Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stem cell transplantation for corneal stromal disease
2018-000523-14Phase 2Active
- Sponsor
- Miguel Hernández University of Elche
- Start
- Apr 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived mesenchymal stromal cells in keratopathy, Corneal Stromal Dystrophy and keratoconus (2 arms), sponsored by Miguel Hernández University of Elche. Primary endpoints: Uncorrected visual acuity, Best corrected distance visual acuity and 1 more. Started Apr 2018; status: active.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
keratopathyCorneal Stromal Dystrophykeratoconus
Beyond the preview
Go deeper on 2018-000523-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000523-14.